Clinical trial
RN1001(Avotermin) in Scar Improvement Following Breast Augmentation
NCT00436449 · Renovo, Industry · Completed
Key facts
| NCT number | NCT00436449 |
|---|---|
| Title | RN1001(Avotermin) in Scar Improvement Following Breast Augmentation |
| Official title | A Double Blind, Within Subject, Placebo Controlled Randomised Trial to Investigate the Scar Improvement Efficacy of a Single Intradermal Application of RN1001 (Avotermin) in Female Subjects Undergoing Bilateral Breast Augmentation |
| Lead sponsor | Renovo, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Mammaplasty, Cicatrix |
| Intervention type | Drug |
| Interventions | Avotermin |
| Enrollment | 63 |
| Start date | Dec 1, 2004 |
| Primary completion | Oct 1, 2007 |
| Completion | Jan 1, 2008 |
| First posted | Feb 19, 2007 |
| Last update posted | Aug 14, 2008 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: